ArticleScientific reports2025
Obesity exacerbates experimental colitis due to the activation of the local renin-angiotensin system in the colon.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Dietary Flavonoids as Cross-System Modulators of Hypertension and Intestinal Permeability.Molecules (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Obesity is recognized as a risk factor for inflammatory bowel disease (IBD) and may contribute to its progression. However, the underlying mechanisms remain unclear. This study aimed to investigate the impact of high-fat diet (HFD)-induced obesity on the development of experimental colitis, with a particular focus on the role of the gut renin-angiotensin system (RAS) in this process. C57BL/6J mice were assigned to either a low-fat diet (LFD) or HFD for 10 weeks to establish an obesity model.The severity of colitis was significantly greater in obese mice compared to those fed the LFD. Additionally, obesity was associated with increased levels of IL-6, IFN-γ, and TNF-α, while simultaneously downregulating the expression of occludin proteins in the colon, leading to increased colonic permeability in the obese mice. Following colitis induction, HFD -induced obesity activated the RAS by upregulating the expression of angiotensin II receptor, angiotensinogen, and renin in the colon. Treatment with a RAS inhibitor significantly alleviated the symptoms of colitis in the obese mice. These findings suggest that HFD-induced obesity enhances intestinal mucosal barrier permeability and exacerbates mucosal inflammation through the activation of the local RAS, thereby promoting colitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.